Antagonists of growth hormone-releasing hormone cross the blood-brain barrier: a potential applicability to treatment of brain tumors.
about
Testing the neurovascular hypothesis of Alzheimer's disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-beta protein, and impairs cognitionA pegylated growth hormone receptor antagonist, pegvisomant, does not enter the brain in humans.Assessment of effective absorbed dose of (111)In-DTPA-Buserelin in human on the basis of biodistribution rat data.Potential of growth hormone-releasing hormone antagonists (JV-1-36 and JV-1-42) for the treatment of brain tumours.Beneficial effects of novel antagonists of GHRH in different models of Alzheimer's diseaseKnocking down gene expression for growth hormone-releasing hormone inhibits proliferation of human cancer cell lines.Targeting potassium channels for increasing delivery of imaging agents and therapeutics to brain tumors.Inhibition of U-87 MG glioblastoma by AN-152 (AEZS-108), a targeted cytotoxic analog of luteinizing hormone-releasing hormone.Growth hormone releasing hormone (GHRH) signaling modulates intermittent hypoxia-induced oxidative stress and cognitive deficits in mouse.Potentiation of cytotoxic chemotherapy by growth hormone-releasing hormone agonistsIn vivo methods to study uptake of nanoparticles into the brain.Suppression of the proliferation of human U-87 MG glioblastoma cells by new antagonists of growth hormone-releasing hormone in vivo and in vitro.Protective effects of an anti-melanocortin-4 receptor scFv derivative in lipopolysaccharide-induced cachexia in rats.Magnetoelectric nanoparticles for delivery of antitumor peptides into glioblastoma cells by magnetic fields.Prognosis in human glioblastoma based on expression of ligand growth hormone-releasing hormone, pituitary-type growth hormone-releasing hormone receptor, its splicing variant receptors, EGF receptor and PTEN genes.
P2860
Q33576221-54FAA880-191A-416F-8BB4-FC50D46A1F3BQ34032058-2B3D1648-B001-4777-BF7E-A6AFF8C49994Q34371904-93E2CCBB-724D-4864-958E-C0DDD57D38B9Q36322087-D3B1B033-AB80-4A87-BB53-2006EC5971BCQ36576387-24DE55A8-B017-4347-8A86-4562D63479BCQ36696448-CDBC2093-6E11-487F-9387-FC5409D9F773Q36881899-77B39C0A-94D2-4AAE-8F3C-6C22A2F27262Q37029375-61C6AB80-81A4-4CD9-9DA8-4AA38135C3CAQ37364745-8C99324D-7B9B-4182-872F-51C91811173BQ37495105-DE51C1DA-E338-4F7A-8087-54EA559F85D9Q37798178-9E068F7F-2EB2-4BAD-BBB5-272C26842E33Q39201247-038CDD77-DB8F-4E8C-922B-AEEECD7F6EF0Q41845215-3C46366A-251A-43D4-8082-04C70E976960Q47652837-2C2E560C-8AD8-437B-B1BD-2D2A2C8D785FQ48749343-2D55EB96-C13C-4950-A9FA-4587DD72F2E7
P2860
Antagonists of growth hormone-releasing hormone cross the blood-brain barrier: a potential applicability to treatment of brain tumors.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Antagonists of growth hormone- ...... to treatment of brain tumors.
@ast
Antagonists of growth hormone- ...... to treatment of brain tumors.
@en
type
label
Antagonists of growth hormone- ...... to treatment of brain tumors.
@ast
Antagonists of growth hormone- ...... to treatment of brain tumors.
@en
prefLabel
Antagonists of growth hormone- ...... to treatment of brain tumors.
@ast
Antagonists of growth hormone- ...... to treatment of brain tumors.
@en
P2860
P356
P1476
Antagonists of growth hormone- ...... to treatment of brain tumors.
@en
P2093
Jozsef L Varga
Laura B Jaeger
P2860
P304
12495-12500
P356
10.1073/PNAS.0504163102
P407
P577
2005-08-23T00:00:00Z